泌尿器科領域におけるブラダロン錠の臨床的検討

概要

論文の詳細を見る
Flavoxate was administered to 225 patients with pollakisuria and bladder irritation, who visited 12 urological clinics in Keiji district. Improvement of urinary frequency was observed in patients with nervous pollakisuria, cystitis, chronic prostatitis, BPH and irritable bladder (P<0.01). Clinical evaluation showed that overall effectiveness rate was 69.3%. As for nervous pollakisuria and irritable bladder, its effectiveness rate was 61.7%. No statistically significant difference in the effectiveness rate was obtained between the 600 mg/day group and the 1200 mg/day group. Regarding the treatment period, a significant difference was observed between the 2-week-treatment group and the 1-week-treatment group. No significant difference was observed in relation to sex or age. No serious major side effects were noted except for slight gastro-intestinal disorders seen in 8 patients out of 227 cases.